Objectives: To assess the dietary intake of people with coeliac disease (CD) and to determine if they are meeting the current dietary reference values (DRVs). To compare dietary intakes of people with CD to the dietary intake of the general population. The nutritional contribution of gluten-free products (GFPs) and current purchasing trends was also evaluated. Subjects/Methods: 106 patients were invited to participate via post. Three-day food diary to assess intake and a short simple questionnaire that looked at purchasing trends of GFP. Results: Forty-nine patients returned the food diary and 48 returned the questionnaire. Patients were found to have a low intake of energy, non-starch polysaccharides (NSPs), vitamin D and calcium. They were obtaining a significantly lower proportion of energy from fat and a significantly higher proportion of energy from protein than the DRVs (Po0.05). Intake was comparable to the general population for most nutrients, except they had a significantly greater intake of protein, a lower intake of fat and a significantly lower intake of vitamin D (Po0.05). Specialist GFP, especially those obtained on prescription, were an important source of energy, carbohydrate, NSP, calcium and iron. Conclusions: Patients with CD are at risk of having an inadequate intake of calcium, NSP and vitamin D. Specialist GFP, which were obtained on prescription, helped patients get a balanced diet and without these patients would be at an increased risk of many deficiencies.
Introduction
Coeliac disease (CD) is an autoimmune inflammatory condition of the small intestinal, triggered by ingestion of gluten in susceptible individuals (Fasano and Catassi, 2001) . Gluten is the name for the amino acids found in wheat (gliadin), rye (secalin) and barley (hordein). Exposure to gluten causes villous atrophy. The only treatment for CD is a lifelong gluten-free diet (GFD).
Traditionally patients with CD were advised to exclude oats. Recent research is persuasive in suggesting that most adults can tolerate moderate (o50 g/day) amounts of oats safely and it is now advised that oats can be included as they add fibre and variety. Some patients may however get a reaction (Storsrud et al., 2003; Arentz-Hansen et al., 2004; Silano et al., 2007) . An additional problem is cross-contamination due to the harvesting, storage and milling process. Therefore, patients must ensure that oats eaten are free from contamination.
The GFD means many staple foods such as bread, flour and pasta have to be excluded, which are important sources of energy, protein, carbohydrate (CHO), iron, calcium, niacin and thiamin (Henderson et al., 2002) . Many processed foods also contain gluten and therefore must be excluded. Potentially this could have a major affect on nutritional status if they are not replaced with appropriate alternatives. Gluten-free products (GFPs) are available on prescription in the UK to help replace these staple foods. Luxury items, such as cakes, chocolate biscuits and pastries, are available to buy over the counter in chemists, by mail order and in supermarkets.
A review of the literature was undertaken (December 2003 and September 2004) examining articles on nutritional status of patients with CD, the nutritional quality of the GFD and impact of non-compliance. Articles included were those in English and those in adults.
A good clinical response is usually seen with the GFD; however, a number of authors have reported evidence of persisting nutritional deficiencies (Bardella et al., 1985; Collins et al., 1986; Bode et al., 1991; Varkonyi et al., 1992; McFarlane et al., 1995; Thompson, 1997 Thompson, , 2000 Grehn et al., 2001; Hallert et al., 2002) . Often the continued ingestion of small amounts of gluten is held responsible for this. However, lower body weight and body mass index, and poor vitamin status could not be attributed to malabsorption as normal intestinal permeability has been found (Bardella et al., 2000; Hallert et al., 2002) . Therefore, it is possible that it is the GFD itself that could be causing these deficiencies by not providing adequate nutrition.
Little research has been carried out on the nutritional adequacy of the GFD in terms of macronutrients, and authors have arrived at conflicting results (Table 1) (Bjorkman et al., 1985; Collins et al., 1986; Kemppainen et al., 1995; McFarlane et al., 1995; Bardella et al., 2000; Capristo et al., 2000; Grehn et al., 2001) . Bjorkman et al. (1985) and Bardella et al. (2000) found that the GFD resulted in a significant decrease in mean energy intake and significantly lower total daily intake of energy than controls, whereas Kemppainen et al. (1995) found intakes of energy were significantly greater in patients with CD compared to the controls (Po0.05). Collins et al. (1986) found that 24% patients had a lower energy than the estimated average requirements (EARs). Grehn et al. (2001) compared the intakes of patients with CD to data from a Swedish National Survey (cited in Grehn et al., 2001 ) and found energy intakes were below reference value for both groups, but patients with CD were having a higher percentage of energy from fat and a lower percentage of energy from CHO.
The literature lacks any assessment of the contribution from prescription GFP and commercial GFP to the nutrient intake of patients with CD. Since the study by McFarlane et al. (1995) was published, the variety of GFP has increased, palatability has improved and products have become more widely available in supermarkets, health food shops and over the Internet. More prescription products are being fortified with iron, calcium and non-starch polysaccharide (NSP). Thus there is a need for more up-to-date information about the nutritional adequacy of the GFD in British patients with CD and the contribution that both prescription and commercial GFP make. 
Methods
A cross-sectional postal survey was carried out, including a 3-day unweighed food diary and a questionnaire. Ethical approval was provided by Central Manchester Research Ethics Committee (REC). All patients with a confirmed diagnosis of CD attending an adult Coeliac Clinic at Manchester Royal Infirmary were invited to participate (n ¼ 106). The results were compared to a 'control group' using the data from the National Diet and Nutrition Survey's (NDNS) (Finch et al., 1998; Gregory et al., 2000; Henderson et al., 2002 Henderson et al., , 2003a . This group is considered to be representative of the 'general population' in the UK. The NDNS for people aged 4-18 years included 1711 7-day weighed food diaries (Gregory et al., 2000) . The NDNS for adults aged 19-64 years included 1724 7-day weighed food diaries and the data for the elderly (465years) used a 4-day weighed diary from 1275 people. Only data from free-living people was used as our sample included only free-living individuals. The data from the NDNS is presented as average daily intakes (mean and standard deviation). The current sample was compared to data from the corresponding age and sex groups as per the NDNS. The results were also compared to the dietary reference values (DRVs) (DoH, 1991) that are the most recent recommended daily amounts for the UK population.
Instructions were provided on how to complete the diary and also on how to use household measures. Three days was chosen (2 week days and 1 weekend day). Any discrepancies in the data returned were resolved by telephoning the patient.
A questionnaire was used to obtain information about which GFPs patients got on prescription, which were bought commercially and from where, and whether or not patients would be willing to buy the prescription products commercially if they were unavailable on prescription. Cost of GFP was looked at (Appendix A1).
Stamped addressed envelopes were provided and a followup letter was sent. All the information was anonymised.
A pilot survey was carried out at two clinics to check readability, comprehensiveness and content of all the information provided to subjects. Only minor amendments were made.
Information on nutritional content of GFP was obtained from manufacturers and added to the dietary analysis programme 'CompEat 5' (Nutrition Systems, 1999, London), which was then used to analyse the food diaries and to calculate the estimated intakes of energy, fat, protein, CHO, NSP, calcium, folate, vitamin B12 and vitamin D. SPSS (version 11, Chicago, IL, USA) was used for statistical analysis of the data. Means and medians were compared to see if data were normally distributed. The groups were split by sex and age into two categories 19-64 years, and 65 years and above to allow comparison to the NDNS and DRVs. The proportion of patients who had intakes above and below the reference nutrient intake (RNI) and the lower reference nutrient intake (LRNI) were compared using w 2 -goodness-of-fit exact test. The RNI is two notional standard deviations below the EAR. Intakes above this amount are almost certainly adequate for 97.5% of the population. The LRNI is two notional standard deviations below the mean and represents the lowest intakes that will meet the needs of some individuals (2.5% of population). Intakes below this level are almost certainly inadequate for most individuals. In addition to the RNI and LRNI for calcium, the estimated intake of calcium was also compared to 1500 mg, which is the recommended amount of calcium for patients with CD by the National Osteoporosis Foundation. The t-test was used to compare the results of the patients with CD to the general population. A significance of Po0.05 was used.
Results
Forty-nine patients returned the food diary, giving a response rate of 46. A total of 48 food diaries were included in the analysis. There were more females (n ¼ 35, 75.5%) than males (n ¼ 12, 24.5%), reflecting gender ratios in the initial sample. The response was similar for males (44%) and females (48%). The mean age (s.d.) of respondents was 58.6 (717) years, 10 years higher than the mean age of the non-respondents, 48.2 (78.9) years. Respondents had been diagnosed for longer 8.9 (711.2) years compared to 6.1 (78.9) years respectively. Four patients (8%) reported taking nutritional supplements (calcium and vitamin D). These were not included in the food analysis, and data presented is for intakes from food sources only.
Results compared to the DRVs Mean daily total energy intake was 7238 (72392) kJ, 8437 (71343) kJ for males and 6838 (71668) kJ for females (Table 3) . A significant proportion of the sample had a reported intake that below the EAR(Po0.05; Table 2 ).
Dietary survey of patients with coeliac disease L Kinsey et al Specialist GFP provided 22% of total daily energy intake, 15% came from prescription GFP (Figure 1) .
Mean daily intake of protein was 75 (723) g, 80 (716) g for males and 74 (725) g for females (Table 3) . Mean daily intake of protein was in excess of the RNI. A significant proportion of the sample was meeting the RNI for protein (Po0.05). Protein provided on average 18% of energy. This was significantly higher than the DRV for percentage of total daily energy from protein (Po0.05; Table 4 ). Forty-four (96%) patients were exceeding the DRV for percentage of energy from protein (Table 2) .
Mean daily intake of CHO was 227 (767) g, 270 (763) g for males and 213 (762) g for females (Table 3) . CHO provided a total of 49% of daily energy. Significantly, more patients had an intake of CHO above (n ¼ 34) the DRV for percentage of energy than below (n ¼ 14; Po0.05). GFP provide a mean of 31% of total daily CHO intake, 22% from prescription GFP and 9% from commercially bought GFP (Figure 1) .
Mean daily intake of fat was 59 (720) g, 63 (721) g for males and 58 (719) g for females (Table 3) . Thirty-one percent of total daily energy came from fat. This is significantly lower than the DRV for percentage of energy from fat (Po0.05).
Mean daily intake of NSP was 12 (75) g, 15 (74) g for males and 12 (75) g for females. A significant proportion (n ¼ 47) had an intake of NSP below the recommended average intake of 18 g per day (Po0.05). GFP provided 28% of the total daily NSP, 22% from prescription GFP (Figure 1) .
Mean daily intake of vitamin B12 was above RNI (Table 5) . In patients where an RNI for vitamin D was appropriate (450 years, n ¼ 28), all had an intake below this level (Po0.05).
Mean daily intake of iron was above the RNI for patients aged 19-64 years, but was below the RNI in females aged 65 years and above. GFP provided 17% of total daily iron intake, of which 16% is from prescription GFP (Figure 1 ). Significantly more patients had an intake above the LRNI for iron (Po0.05).
Mean intake of calcium was 866 (7332) mg, 1076 (7321) mg for males and 797 (7309) mg for females (Table 3 ). More females (n ¼ 15, 42%) than males (n ¼ 15, Dietary survey of patients with coeliac disease L Kinsey et al 42%) had a calcium intake below the RNI. Patients with CD are advised to have 1500 mg of calcium/day (National Osteoporosis Foundation). The significant majority (n ¼ 45) had an intake below this (Po0.05) ( Table 2 ). The main food source of calcium is from milk and milk products, 40% of total daily calcium intake. GFP provided 22% of daily calcium intake, 21% from prescription GFP (Figure 1) .
Results compared to the general population (NDNS)
Energy intake for patients with CD was comparable with the intakes of the general population (Table 3) . Patients with CD obtained a comparable percentage of their total energy from CHO compared to the general population, 49 and 48%, respectively (Table 4) , compared with the NDNS data. Patients with CD obtained significantly less of their total energy from fat, 31% in comparison to 35%, and obtained a significantly higher percentage of energy from protein, 18% compared to 16% (Po0.05; Table 4 ). Patients with CD have a higher mean daily intake of protein than the general population, this is significant for those aged 19-64 years (Po0.05; Table 3 ). The nutrient contribution of foods is shown in Figure 2 . The contribution, of cereal and cereal products and milk and milk products, is greater with age in both groups, and the contribution of meat and meat products is less with age in both groups (Figures 2 and 3 ). There is no significant difference between mean daily intake of iron between patients with CD and the general population. Both groups exceed the RNI for folate. Mean daily intake of calcium is higher in patients with CD than the general population, but this does not reach statistical significance; however, a greater proportion of patients with CD have an intake of calcium below the LRNI than the general population (Po0.05). In patients aged 19-64 years, mean daily intake of vitamin D was significantly lower in female patients with CD than the general population (Po0.05). Intake of NSP was comparable with that of the general population and both groups had average intake below the recommended 18 g/day (Table 3) . Dietary survey of patients with coeliac disease L Kinsey et al GFP use and purchasing trends It was intended that the dietary intakes and purchasing patterns of those patients who do receive prescription GFP and those who do not would be compared; however, due to only a very small proportion of our sample (n ¼ 3, 6%) not receiving prescription GFP it was not possible to carry out this. Over half (n ¼ 28, 62%) get their prescriptions for GFP every 3-4 weeks. Seventeen percent (n ¼ 8) of patients get their products every 5-6 weeks. The majority of patients (n ¼ 42, 87%) also buy GFP commercially in addition. The supermarket is the most popular place to buy these with 83% (n ¼ 35) patients using this as a regular source of obtaining GFP. Health food shops are the second most popular place, 27% of patients (n ¼ 11) buy some GFP here. Only a small amount of patients use local shops and the pharmacist to get GFP (n ¼ 2, 5% and n ¼ 1, 2% respectively). None of the samples obtained any GFP via mail order, telephone order or over the Internet.
The most popular GFP that patients buy in addition to prescription GFP are chocolate bars, cakes, sauces, sweet biscuits and 'others'. They rarely bought any of the 'staple' GFP, such as bread, commercially.
On average a patient with CD will spend d6.43 (710.42) on their prescription GFP and an additional d10.41 ( þ 6.43) on commercially bought GFP a month. Over a 12-month period this would cost a patient with CD a total of d202.13.
Discussion
This is the first survey to look at the nutritional contribution of prescription and commercial GFP, and the first to look at purchasing trends of patients with CD. It fulfils the need for a more up-to-date assessment of the dietary intake of patients with CD. Only one other survey has compared the intake of this group to the general British population (McFarlane et al., 1995) .
The results suggest that patients with CD consume less than the recommended amounts for energy, NSP, vitamin D Table 5 Number of patients (%) with average daily intakes of micronutrients below the lower reference nutrient intake a by sex and age in comparison to the NDNS b 19-64 years 65 years and above
1 (4) 18 (1) 0 (0) 7 (0.5) Iron 2 (7) 231 (13) 2 (11) 42 ( Dietary survey of patients with coeliac disease L Kinsey et al and calcium and consume amounts in excess of current dietary recommendations of protein (as do the general population). EAR is a notional mean requirement that has been set as the average energy requirement for any population. Differences between the estimated intakes of energy and the EAR could be due to a biased low estimate of intake due to misreporting or patients modifying their diets during the recording period. Previous studies have validated food diaries and found patients underestimate energy requirements by 25% (Grehn et al., 2001; Hallert et al, 2002) . Underestimation of energy also indicates that the results are an underestimation of all the nutrients and this need to be considered when interpreting all of the results. However, this bias may also apply to the data collected from the general population.
The mean intake of CHO as a proportion to percentage of energy was not significantly different to the DRV (DoH, 1991) . This is different to findings by Grehn et al. (2001) who found that patients with CD were having a mean daily intake of energy from CHO that was lower than the recommended amount. This difference may be due to the different countries where these studies were carried out (Sweden and the UK) and thus differences in dietary habits, and the different recommendations that were being compared.
In the UK, the DRV for fat is a maximum of 35% of total energy and therefore the fact that some patients are having under this quantity is not a significant concern. Of greater concern is that over one-third of patients are exceeding the recommended percentage of energy from fat. In contrast to findings in previous studies (Kemppainen et al., 1995; Bardella et al., 2000; Capristo et al., 2000) our results showed that patients with CD are actually having a lower average intake of fat than the general population, and get a smaller proportion of total energy from fat. Only one study has found similar findings and this was only in females (Bjorkman et al., 1985) . The reason for this lower intake of fat on a GFD is not known and would need further exploration. One possible reason may be that because of CD these patients cannot have a lot of the high fat foods as they often the processed foods, which often contain gluten. Also it may be that those patients who responded are more interested in their diet, and more health conscious than non-respondents. Our results indicate that patients with CD have a higher proportion of energy from protein than fat when compared to the general population. This finding may reflect changes in dietary habits of people in the UK in the last 10 years.
An inadequate intake of NSP can cause problems such as constipation (Kemppainen et al., 1995; Grehn et al., 2001) . Constipation is a symptom of CD when gluten is being consumed and therefore inadequate intakes of NSP, which we found, can make assessing compliance/contamination of the GFD difficult. Our results indicated that there was not a significant difference in the intake of NSP in patients with CD compared to the general population. This contradicts earlier studies, which have shown that the GFD results in a reduced intake of NSP (Kemppainen et al., 1995; Grehn et al., 2001) . In recent years manufacturers of GFP have brought out high fibre ranges of breads and flour mixes which may explain the difference in our findings.
The findings of inadequate vitamin D intake in those individuals 465 years is a concern because vitamin D is necessary for calcium homeostasis and hypovitaminosis D and can cause osteomalacia. There are few dietary sources of Figure 3 Percentage contribution of food types to average daily total energy for patients with coeliac disease aged 65 years and above compared to results from the NDNS (Finch et al., 1998) . A deficiency in calcium can lead to long-term problems such as osteoporosis and treating this is costly. Grehn et al. (2001) also found intake of calcium to be an area of concern and osteoporosis is one of the most common complications of CD, with approximately 75% of newly diagnosed patients having some degree of bone loss and therefore the National Osteoporosis Foundation have set the recommended intake for calcium higher for patients with CD than that for the general population. The gastroenterology society group of the British Dietetic Association supports this increased recommended intake, although the evidence base for this value is currently being reviewed by the group.
It is important to consider our results in relation to the general population as some of the findings may be typical of the British population and not a result of the GFD and some may be specific to patients with CD. By comparing the two groups it gave the opportunity to make a judgement as to whether or not patients with CD are at an elevated risk of having an unbalanced diet than the general population. Significant differences were seen in protein, fat, vitamin D, vitamin B12 and folate. Differences were also seen in the food source of energy.
GFP are a very important source of NSP, calcium, iron, CHO and energy, as shown in this study. Patients with CD have an intake of energy and CHO, which is comparable to the general population. However, this is only the case because patients get a major percentage of these nutrients from GFP, in particular prescription GFP. This highlights the clinical importance of these prescription GFPs and the need for health professionals to ensure that these are utilised. These products are more likely to be fortified with calcium, iron and NSP than those commercially available. It is also important that health professionals support the availability of these of GFP on prescription.
This survey has highlighted the potential nutritional inadequacies in the GFD that may be contributing to the nutritional deficiencies that have been identified in patients with CD in previous studies (Bode et al., 1991; Varkonyi et al., 1992; McFarlane et al., 1995; Thompson, 1997 Thompson, , 2000 Grehn et al., 2001; Hallert et al., 2002) . These nutritional inadequacies could be increasing patient's risk of osteomalacia, osteoporosis and bowel problems. It has highlighted the importance of having GFP available on prescription and the need to place adequate emphasis on using these in the dietetic treatment of CD. In particular GFP that are high in NSP, and those that are fortified with calcium and iron are important in patients overall dietary intakes. Thus it is likely that removal of this group of foods would result in deterioration in the nutritional adequacy of the diets of many patients with CD.
Continued
Telephone Pharmacist Other 7. How much do you spend on gluten-free products a month? State how much is on prescriptions and how much is non-prescription products.
